3:placebo
Sponsors
Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Jiangsu Provincial Center for Disease Control and Prevention, Peking Union Medical College Hospital, Hospital of Acupuncture & Moxibustion, CACMS, Fourth Military Medical University
Conditions
Acute mountain sicknessModerate to severe atopic dermatitisNon-alcoholic fatty liver diseaseNovel Coronavirus Pneumonia (COVID-19)sport fatigue
Phase 2
A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)
Active, not recruitingChiCTR2000031781
Start: 2020-04-09Updated: 2020-04-13
A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, pharmacokinetics and pharmacodynamics of QX005N injection in adult subjects with moderate to severe atopic dermatitis (phase II)
Active, not recruitingChiCTR2200063605
Start: 2022-09-13Updated: 2023-04-17
Phase 4
Ginkgo biloba prophylaxis for acute mountain sickness
Active, not recruitingChiCTR-TRC-11001412
Start: 2011-06-28Updated: 2017-04-18
Demonstration technology and application promotion of Lingguizhugan decoction treating non-alcoholic fatty liver disease with yang deficiency of spleen
Active, not recruitingChiCTR1800014364
Start: 2018-03-01Updated: 2018-07-31